Key Takeaways
- • Kaspar Hållsten now serves as portfolio manager for the newly launched Rhenman Healthcare Next Generation L/S, a long/short fund focused on smaller healthcare companies.
- • His grandfather, Bertil Hållsten, founded and managed SEB's pharmaceutical fund in the 1980s, establishing the family's link to healthcare investing.
- • Hållsten describes his grandfather as a demanding analyst who tested every investment case thoroughly but became enthusiastic and willing to take risk once convinced of a company and its management.
- • The fund's core philosophy, inherited from his grandfather, is to invest over years rather than quarters and to understand companies rather than react to short-term noise.
Summary
Hållsten credits his grandfather as a formative mentor. "Having him as a mentor has been very important to me and is a big part of the reason I do this today," he says, calling him "one of the most knowledgeable and wise people I've ever met." According to Hållsten, his grandfather, who died two years ago, was rigorous in evaluating investments. "He was extremely critical and would pull any investment case apart piece by piece," he recalls. Once convinced, however, the elder Hållsten became "genuinely enthusiastic and optimistic" and was willing to take on risk when he believed in a company and its management.
A principle that has stayed with Kaspar is his grandfather's emphasis on time horizon. "He used to say that investing was about truly understanding companies, not reacting to short-term noise," he says. Hållsten states this philosophy guides both his own approach and the new fund. The strategy's focus on smaller healthcare companies also carries personal meaning for him. "Launching this fund has been exciting, and I know he would have been proud of it," he says.
The profile does not disclose fund size, launch date, or performance figures.
{"categories":["hedge-fund","alternative-investment"],"content_type":"interview","keywords":["healthcare investing","long/short equity","small-cap healthcare","Rhenman Healthcare Next Generation L/S","SEB pharmaceutical fund","portfolio management","succession","long-term investing"],"mentioned_companies":["Rhenman","SEB"],"mentioned_people":["Kaspar Hållsten","Bertil Hållsten"],"has_cta":false,"translated_title":null}
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.